VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.38 Million EUR | -71.9% |
| 2022 | 12.05 Million EUR | -38.83% |
| 2021 | 19.7 Million EUR | 505.62% |
| 2020 | 3.25 Million EUR | -36.89% |
| 2019 | 5.15 Million EUR | -4.2% |
| 2018 | 5.38 Million EUR | -28.21% |
| 2017 | 7.49 Million EUR | 386.19% |
| 2016 | 1.54 Million EUR | -29.14% |
| 2015 | 2.17 Million EUR | 1226.83% |
| 2014 | 164 Thousand EUR | -21.9% |
| 2013 | 210 Thousand EUR | -39.83% |
| 2012 | 349 Thousand EUR | -80.72% |
| 2011 | 1.81 Million EUR | 2.84% |
| 2010 | 1.76 Million EUR | -23.97% |
| 2009 | 2.31 Million EUR | 54.33% |
| 2008 | 1.5 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.84 Million EUR | -9.98% |
| 2024 Q1 | 3.16 Million EUR | -6.55% |
| 2023 Q2 | 12.58 Million EUR | 7.59% |
| 2023 Q1 | 11.69 Million EUR | -2.95% |
| 2023 Q4 | 3.38 Million EUR | -71.63% |
| 2023 Q3 | 11.93 Million EUR | -5.15% |
| 2023 FY | 3.38 Million EUR | -71.9% |
| 2022 Q3 | 12 Million EUR | -33.49% |
| 2022 Q1 | 19.38 Million EUR | -1.65% |
| 2022 FY | 12.05 Million EUR | -38.83% |
| 2022 Q2 | 18.04 Million EUR | -6.9% |
| 2022 Q4 | 12.05 Million EUR | 0.44% |
| 2021 Q3 | 1.83 Million EUR | -21.54% |
| 2021 Q4 | 19.7 Million EUR | 973.37% |
| 2021 FY | 19.7 Million EUR | 505.62% |
| 2021 Q1 | 2.81 Million EUR | -13.4% |
| 2021 Q2 | 2.34 Million EUR | -16.96% |
| 2020 FY | 3.25 Million EUR | -36.89% |
| 2020 Q1 | 4.67 Million EUR | -9.29% |
| 2020 Q4 | 3.25 Million EUR | -12.01% |
| 2020 Q3 | 3.69 Million EUR | -11.55% |
| 2020 Q2 | 4.18 Million EUR | -10.61% |
| 2019 Q1 | 5.72 Million EUR | 6.34% |
| 2019 FY | 5.15 Million EUR | -4.2% |
| 2019 Q3 | 4.71 Million EUR | -9.61% |
| 2019 Q2 | 5.21 Million EUR | -8.91% |
| 2019 Q4 | 5.15 Million EUR | 9.42% |
| 2018 Q4 | 5.38 Million EUR | -15.07% |
| 2018 Q3 | 6.33 Million EUR | -6.55% |
| 2018 Q2 | 6.78 Million EUR | -14.84% |
| 2018 Q1 | 7.96 Million EUR | 6.22% |
| 2018 FY | 5.38 Million EUR | -28.21% |
| 2017 Q1 | 1.49 Million EUR | -3.24% |
| 2017 Q4 | 7.49 Million EUR | -13.15% |
| 2017 Q3 | 8.63 Million EUR | -4.88% |
| 2017 Q2 | 9.07 Million EUR | 508.24% |
| 2017 FY | 7.49 Million EUR | 386.19% |
| 2016 Q2 | 2.03 Million EUR | -4.46% |
| 2016 Q4 | 1.54 Million EUR | -20.47% |
| 2016 FY | 1.54 Million EUR | -29.14% |
| 2016 Q3 | 1.93 Million EUR | -4.62% |
| 2016 Q1 | 2.12 Million EUR | -2.21% |
| 2015 Q1 | 848 Thousand EUR | 417.07% |
| 2015 Q2 | 998 Thousand EUR | 17.69% |
| 2015 Q3 | 809 Thousand EUR | -18.94% |
| 2015 Q4 | 2.17 Million EUR | 168.97% |
| 2015 FY | 2.17 Million EUR | 1226.83% |
| 2014 Q2 | 177 Thousand EUR | -8.29% |
| 2014 Q3 | 160 Thousand EUR | -9.6% |
| 2014 Q4 | 164 Thousand EUR | 2.5% |
| 2014 Q1 | 193 Thousand EUR | -8.1% |
| 2014 FY | 164 Thousand EUR | -21.9% |
| 2013 Q4 | 210 Thousand EUR | -39.66% |
| 2013 FY | 210 Thousand EUR | -39.83% |
| 2013 Q1 | 334 Thousand EUR | -4.3% |
| 2013 Q2 | 347 Thousand EUR | 3.89% |
| 2013 Q3 | 348 Thousand EUR | 0.29% |
| 2012 Q2 | 719 Thousand EUR | -44.52% |
| 2012 Q1 | 1.29 Million EUR | -28.4% |
| 2012 Q3 | 703 Thousand EUR | -2.23% |
| 2012 FY | 349 Thousand EUR | -80.72% |
| 2012 Q4 | 349 Thousand EUR | -50.36% |
| 2011 Q2 | 2.31 Million EUR | -5.9% |
| 2011 Q1 | 2.45 Million EUR | 39.66% |
| 2011 Q4 | 1.81 Million EUR | 7.23% |
| 2011 FY | 1.81 Million EUR | 2.84% |
| 2011 Q3 | 1.68 Million EUR | -27.02% |
| 2010 Q4 | 1.76 Million EUR | 34.15% |
| 2010 Q1 | 1.37 Million EUR | -40.6% |
| 2010 FY | 1.76 Million EUR | -23.97% |
| 2010 Q2 | 1.31 Million EUR | -4.58% |
| 2010 Q3 | 1.31 Million EUR | 0.0% |
| 2009 Q2 | 1.43 Million EUR | 0.0% |
| 2009 Q4 | 2.31 Million EUR | 0.0% |
| 2009 FY | 2.31 Million EUR | 54.33% |
| 2008 FY | 1.5 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.48 Billion EUR | 99.968% |
| Fresenius SE & Co. KGaA | 13.24 Billion EUR | 99.974% |
| LIMES Schlosskliniken AG | 10.09 Million EUR | 66.432% |
| M1 Kliniken AG | 1.87 Million EUR | -80.64% |
| Maternus-Kliniken Aktiengesellschaft | 53.96 Million EUR | 93.723% |
| MEDICLIN Aktiengesellschaft | 66.41 Million EUR | 94.901% |
| RHÖN-KLINIKUM Aktiengesellschaft | 141.77 Million EUR | 97.611% |